Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 169,268 | 244,785 | 496,460 | 514,942 | 237,481 |
| Marketable Securities | 261,348 | 459,033 | 291,421 | 272,897 | 257,314 |
| Receivables | 111,732 | 11,535 | 8,887 | 10,498 | 2,802 |
| Inventories | 70,870 | 1,136 | 1,224 | 790 | 1,460 |
| Other current assets | 81,700 | 0 | 0 | 0 | 0 |
| TOTAL | $698,224 | $717,531 | $799,073 | $799,752 | $499,480 |
| Non-Current Assets | |||||
| PPE Net | 29,048 | 794 | 633 | 32 | 18 |
| Investments And Advances | 259,717 | 289,733 | 188,971 | 170,756 | 143,643 |
| Intangibles | 261,634 | 17,475 | 12,576 | 14,153 | 3,320 |
| Other Non-Current Assets | 56,680 | 26,299 | 4,730 | 6,077 | 2,527 |
| TOTAL | $607,079 | $334,301 | $206,910 | $191,018 | $149,508 |
| Total Assets | $1,305,303 | $1,051,832 | $1,005,983 | $990,770 | $648,988 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 50,557 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 72,831 | 752 | 541 | 748 | 39 |
| Accrued Expenses | 18,293 | 5,348 | 4,484 | 2,459 | 2,377 |
| Other current liabilities | 185,773 | N/A | N/A | N/A | N/A |
| TOTAL | $350,804 | $17,185 | $14,260 | $9,758 | $6,740 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,022 | N/A | N/A | N/A | N/A |
| Deferred Revenues | 0 | 183 | 282 | 355 | 293 |
| Other Non-Current Liabilities | -102,676 | 4,615 | 348 | 877 | 0 |
| TOTAL | $39,393 | $4,615 | $515 | $1,294 | $186 |
| Total Liabilities | $390,197 | $21,800 | $14,775 | $11,052 | $6,926 |
| Shareholders' Equity | |||||
| Common Shares | 723,832 | 761,844 | 761,490 | 760,447 | 439,148 |
| Retained earnings | 52,246 | 232,122 | 195,830 | 178,586 | 160,026 |
| Other shareholders' equity | 18,190 | 21,740 | 21,692 | 31,216 | 36,116 |
| TOTAL | $810,731 | $1,030,032 | $991,208 | $979,718 | $642,062 |
| Total Liabilities And Equity | $1,200,928 | $1,051,832 | $1,005,983 | $990,770 | $648,988 |